Product Information

DICLOXACILLIN 250 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.5844 per EA under NDC 59651056501. Its NADAC has been published 198 times since Nov 9, 2022.

FDA first approved this application on Sep 23, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DICLOXACILLIN 250 MG CAPSULE

DICLOXACILLIN SODIUM
$0.5844per EA

Strength

250 mg/1

NDC

59651056501

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DICLOXACILLIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA216845

FDA Approved

9/23/2022

TE Code

AB

On Market Since

9/23/2022

Pharmacological Classes

Price Statistics

The NADAC for DICLOXACILLIN 250 MG CAPSULE has been published 198 times since Nov 9, 2022, and over the history we have for it it has risen 10.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5844 per EA
All-time high$0.6071 (Oct 15, 2025)
All-time low$0.3805 (Feb 19, 2025)
52-week high$0.6071
52-week low$0.5421
Median price$0.4586
Average price$0.4901
Largest weekly change+20.6% (Jul 19, 2023)
Weeks tracked198
Tracking sinceNov 9, 2022

Price History

1W

+1.2%

1M

+1.2%

3M

+1.8%

6M

+7.5%

1Y

-3.7%

3Y

+6.5%

5Y

N/A

All

+10.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DICLOXACILLIN SODIUM market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of DICLOXACILLIN 250 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DICLOXACILLIN 250 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.5844 per EA (NDC 59651056501), effective Aug 19, 2026.

How has the price of DICLOXACILLIN 250 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DICLOXACILLIN 250 MG CAPSULE has risen 10.7%. It has been tracked across 198 weekly CMS publications since Nov 9, 2022.

What are the highest and lowest recorded NADAC prices for DICLOXACILLIN 250 MG CAPSULE?

Since Nov 9, 2022, the NADAC for DICLOXACILLIN 250 MG CAPSULE has ranged from a low of $0.3805 (Feb 19, 2025) to a high of $0.6071 (Oct 15, 2025), with a median of $0.4586 per EA.

Are there cheaper alternatives to DICLOXACILLIN 250 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of DICLOXACILLIN 250 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DICLOXACILLIN 250 MG CAPSULE?

DICLOXACILLIN 250 MG CAPSULE (NDC 59651056501) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.